Recombinant urate oxidase (rasburicase) for the prevention and treatment of tumor lysis syndrome in patients with hematologic malignancies.
about
Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancerUrate oxidase for the prevention and treatment of tumor lysis syndrome in children with cancerRasburicase in the management of tumor lysis: an evidence-based review of its place in therapyEmerging role of rasburicase in the management of increased plasma uric acid levels in patients with hematologic malignancies.Clarifying the role of rasburicase in tumor lysis syndrome.Management of tumor lysis syndrome in adults.Rasburicase for the prevention and treatment of hyperuricemia in tumor lysis syndrome.A review of tumour lysis syndrome with targeted therapies and the role of rasburicase.Rasburicase for the treatment of tumor lysis in hematological malignancies.Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancer.Tumor Lysis Syndrome in Multiple Myeloma: An Increasingly Recognized Risk-A Report of Seven Cases.Economic implications of rasburicase treatment in adult patients with tumour lysis syndrome.PEGylation enhancement of pH stability of uricase via inhibitive tetramer dissociation.Arxula adeninivorans recombinant urate oxidase and its application in the production of food with low uric acid content.Tumour lysis syndrome and acute kidney injury in high-risk haematology patients in the rasburicase era. A prospective multicentre study from the Groupe de Recherche en Réanimation Respiratoire et Onco-Hématologique
P2860
Q24194387-7E945496-83B9-40CB-9A54-16952D419A8DQ24234902-15556859-DF9E-4A9A-9916-E96D2E15BCFCQ28082089-592E1391-BDD9-40FE-88FA-0ECF76AC5412Q35683889-9D0C15A3-ED93-4C84-A551-894479C31F59Q36693863-42D745D1-C90F-4F65-911A-7A406A94EE32Q36731440-98555CE3-3E33-4A7A-998C-6F5E33FBBD3AQ37634744-B32974E8-9B33-43F4-9635-0F4B03C96CE4Q37866341-BC736F8D-3F59-4860-B0DF-D83D2688C753Q37978342-CDA81FE3-2654-4CD2-BAA5-43068A7DB390Q38921102-A1F0BD01-81DF-4C4E-8D59-09D4B009DD87Q39134211-002B05AB-6C01-4D77-9F01-01327AE632A4Q40065094-F8D46216-9276-4CD3-AB47-D3A94F76828FQ43944417-E1F3F787-8334-40CB-8EF3-4F82080802AFQ48037790-FE55E2C7-9831-4E30-863A-625CDE2BF519Q56968046-C729A67B-84F3-4444-9FCF-C09F607311B1
P2860
Recombinant urate oxidase (rasburicase) for the prevention and treatment of tumor lysis syndrome in patients with hematologic malignancies.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Recombinant urate oxidase (ras ...... with hematologic malignancies.
@en
Recombinant urate oxidase
@nl
type
label
Recombinant urate oxidase (ras ...... with hematologic malignancies.
@en
Recombinant urate oxidase
@nl
prefLabel
Recombinant urate oxidase (ras ...... with hematologic malignancies.
@en
Recombinant urate oxidase
@nl
P2093
P2860
P356
P1433
P1476
Recombinant urate oxidase (ras ...... with hematologic malignancies
@en
P2093
Der-Cherng Liang
Hung Chang
Kai-Hsin Lin
Lee-Yung Shih
Lin-Yen Wang
Sheng-Fung Lin
Ting-Chi Yeh
P2860
P356
10.1159/000089463
P577
2006-01-01T00:00:00Z